| Product Includes | Product # | Quantity | Mol. Wt | Isotype/Source |
|---|---|---|---|---|
| CD44 (156-3C11) Mouse mAb | 3570 | 20 µl | 80 kDa | Mouse IgG2a |
| Cyclin D1 (92G2) Rabbit mAb | 2978 | 20 µl | 36 kDa | Rabbit IgG |
| c-Jun (60A8) Rabbit mAb | 9165 | 20 µl | 43, 48 kDa | Rabbit IgG |
| LEF1 (C12A5) Rabbit mAb | 2230 | 20 µl | 25-58 kDa | Rabbit IgG |
| Met (D1C2) XP® Rabbit mAb | 8198 | 20 µl | 140, 170 kDa | Rabbit IgG |
| MMP-7 (D4H5) XP® Rabbit mAb | 3801 | 20 µl | 28, 20-22 kDa | Rabbit |
| c-Myc (D84C12) Rabbit mAb | 5605 | 20 µl | 57-65 kDa | Rabbit IgG |
| TCF1/TCF7 (C63D9) Rabbit mAb | 2203 | 20 µl | 48, 50 kDa | Rabbit IgG |
| Anti-mouse IgG, HRP-linked Antibody | 7076 | 100 µl | Horse | |
| Anti-rabbit IgG, HRP-linked Antibody | 7074 | 100 µl | Goat |
Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.
Description
The Wnt/β-Catenin Activated Targets Antibody Sampler Kit provides an economical means to investigate target proteins of the Wnt/β-Catenin signaling pathway. This kit contains enough primary antibody to perform two western blots per primary.
Storage
Background
The Wnt family includes several secreted glycoproteins that play important roles in animal development. β-catenin is a key downstream effector of the Wnt signaling pathway that research studies have shown is implicated in early embryonic development and tumorigenesis in vertebrates (1-3). Following binding of Wnt family proteins to the Frizzled receptor, β-catenin translocates to the nucleus where it interacts with LEF1 and TCF1 to activate canonical targets (4). Accepted canonical targets include CD44, cyclin D1, c-Jun, c-Myc, Met, and MMP-7 (5-11).
- Cadigan, K.M. and Nusse, R. (1997) Genes Dev 11, 3286-305.
- Wodarz, A. and Nusse, R. (1998) Annu Rev Cell Dev Biol 14, 59-88.
- Polakis, P. (1999) Curr Opin Genet Dev 9, 15-21.
- Brantjes, H. et al. (2002) Biol Chem 383, 255-61.
- Zeilstra, J. et al. (2008) Cancer Res 68, 3655-61.
- Shtutman, M. et al. (1999) Proc Natl Acad Sci U S A 96, 5522-7.
- Mann, B. et al. (1999) Proc Natl Acad Sci U S A 96, 1603-8.
- Wilkins, J.A. and Sansom, O.J. (2008) Cancer Res 68, 4963-6.
- Boon, E.M. et al. (2002) Cancer Res 62, 5126-8.
- Brabletz, T. et al. (1999) Am J Pathol 155, 1033-8.
- Clevers, H. and Nusse, R. (2012) Cell 149, 1192-205.
Background References
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.